Jonathan Chang
Stock Analyst at Leerink Partners
(0)
# 5000
Out of 5,331 analysts
132
Total ratings
20.29%
Success rate
-32.12%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
GMAB Genmab | Upgrades: Outperform | 27 | 21.48 | 25.7% | 10 | Feb 13, 2025 | |
VINC Vincerx Pharma | Maintains: Outperform | 80 40 | n/a | n/a | 6 | Oct 8, 2024 | |
IMCR Immunocore Hldgs | Initiates Coverage On: Outperform | 74 | 30.49 | 142.7% | 1 | Apr 29, 2024 | |
NBTX Nanobiotix | Initiates Coverage On: Outperform | 11 | 3.34 | 229.34% | 1 | Dec 8, 2023 | |
NVCR NovoCure | Initiates Coverage On: Outperform | 51 | 18.18 | 180.53% | 1 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 90 75 | 7.29 | 928.81% | 12 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 34 | 10.03 | 238.98% | 9 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 6 | n/a | n/a | 1 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 14 | n/a | n/a | 1 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 18 2 | n/a | n/a | 6 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 100 40 | n/a | n/a | 6 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 3 2 | n/a | n/a | 7 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 48 50 | 9.3 | 437.63% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 30 | 40.82 | -26.51% | 4 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 12 | 1.75 | 585.71% | 8 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 1 | n/a | n/a | 7 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 14 | 0.39 | 3489.74% | 5 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 26 | 5.26 | 394.3% | 5 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 101 95 | 31.19 | 204.58% | 8 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 20 60 | n/a | n/a | 5 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 3 | 0.28 | 971.43% | 8 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 5 4 | n/a | n/a | 5 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 41 28 | 6.47 | 332.77% | 3 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 57 53 | 11.3 | 369.03% | 7 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 50 0 | n/a | n/a | 2 | May 10, 2018 |